What is it about?
Blood flow to the heart can by measured by CT-scans. The paper describes how doctors use a real-world CT myocardial perfusion service to help them care for patients with heart disease.
Featured Image
Photo by Tim Mossholder on Unsplash
Why is it important?
This is not an experimental study, but describes how the results of this clinical service guide decision-making and treatment of patients with coronary artery disease.
Perspectives
The paper describes experiences with patients with real clinical problems faced by cardiologists in daily practice. Questions like did this patient have a heart attack, how much of the heart was damaged, is it safe to treat the patients with medications alone or does the patient need a coronary stenting procedure? are answered with this test. The paper also tracks what happens to these patients up to 14 months after the test results were used to guide treatment. Were they safe? Did they have more heart attacks are some examples.
Dr Kheng-Thye Ho
Mount Alvernia Hospital
Read the Original
This page is a summary of: Systematic assessment of procedural parameters, influence on downstream testing and 12-month outcomes of a CT-myocardial perfusion service, Journal of Cardiovascular Computed Tomography, May 2019, Elsevier,
DOI: 10.1016/j.jcct.2019.04.006.
You can read the full text:
Resources
Contributors
The following have contributed to this page
